Leading Cardiology Researcher & Division Director at NYU Langone Glenn I. Fishman, MD, Awarded American Heart Association Basic Research Prize
The American Heart Association’s 2015 Basic Research Prize was awarded to NYU Langone’s Glenn I. Fishman, MD, in recognition of his outstanding contributions to cardiovascular science and groundbreaking discoveries of the molecular defects associated with cardiovascular diseases, including those responsible for heart rhythm disorders and cardiomyopathies.
“We’re incredibly proud that Dr. Fishman has been recognized by the American Heart Association as a leader in basic cardiology research, which acknowledges his vast achievements in advancing the science of this field,” said Dafna Bar-Sagi, PhD, senior vice president and vice dean for science and chief scientific officer at NYU School of Medicine. “This award celebrates his internationally recognized discoveries that have contributed to the greater understanding of cardiovascular biology and disease, and we’re honored that Dr. Fishman has been chosen to receive this prestigious award.”
The $5,000 basic excellence award was presented to Dr. Fishman during the opening session of the American Heart Association Scientific Sessions 2015 in Orlando, Florida. Dr. Fishman is the William Goldring Professor of Medicine and has been the director of the Leon H. Charney Division of Cardiology at NYU Langone since 2001. He holds professorships in the Departments of Biochemistry and Molecular Pharmacology, Medicine, Physiology, and Neuroscience. Recently, he was appointed vice chair of research in the Department of Medicine.
As a recognized leader in his field, Dr. Fishman has contributed groundbreaking research into the causes of heart disease at the molecular level. His studies have yielded invaluable fundamental information and have had the exciting potential to point medical science toward answers about the sources of cardiovascular diseases, especially those causing arrhythmias and sudden cardiac death. Among Dr. Fishman’s advances has been the creation of genetically engineered animal models that enabled his research teams to explore the molecular abnormalities producing arrhythmias, and to experiment with new techniques to overcome them.
During his career, Dr. Fishman has published extensively in major journals including the AHA’s Circulation, Circulation Research, and Circulation: Arrhythmia and Electrophysiology. Other studies have appeared in Nature, Nature Genetics, the Journal of Clinical Investigation, the Proceedings of the National Academy of Sciences, and the American Journal of Physiology, among others. His research has been funded for more than 25 years by the National Institutes of Health (NIH), the AHA, the state of New York, and several foundations.
Dr. Fishman has been a leader of high-profile national committees, serving as chair of the NIH’s Electrical Signaling, Ion Transport, and Arrhythmias Study Section and as co-chair of the NIH/National Heart, Lung and Blood Institute (NHLBI)/Heart Rhythm Society Workshop on Prediction and Prevention of Sudden Cardiac Death. He is currently president of the Cardiac Electrophysiology Society and a member of the NHLBI Program Project Review Committee. His past honors include election to the American Society of Clinical Investigation, American Association of Physicians, Association of University Cardiologists, and the Harvey Society. An AHA Established Investigator, Dr. Fishman also received the Louis Katz Basic Science Award for Young Investigators. He has served on the Board of Directors of the AHA Founders and the Heart Rhythm Society. He has served on the editorial boards of seven journals including Circulation and Circulation Research.